Benefit from a Blockbuster
The quest to cure cat and dust mite allergies appears an unlikely spark of a revolution. Yet the significance of Circassia Pharmaceutical's (CIR) initial public offering (IPO) is hard to avoid.The Oxford-based concern is the first...
20 March 2014
